BCYC Earnings Date 2026
Bicycle Therapeutics Ltd earnings schedule and quarterly results
Next Earnings Date
TBD
Current Stock Price
$4.22
+3.05% today
Earnings Metrics
EPS (TTM)
$-3.62
P/E Ratio
-1.5
Revenue Growth
338.5%
Market Cap
$0.6B
Earnings History
| Quarter | EPS | Revenue | Net Income |
|---|---|---|---|
| Q4 2024 | $-2.90 | $0.04B | $-0.17B |
| Q4 2023 | $-5.08 | $0.03B | $-0.18B |
Trading Around BCYC Earnings
Before Earnings
- Review analyst expectations and consensus estimates
- Check options implied volatility for expected move
- Consider historical earnings surprises
- Monitor pre-announcement guidance
After Earnings
- Compare actual results to estimates
- Listen to the earnings call for guidance
- Watch for analyst rating changes
- Monitor institutional buying/selling
Get Full BCYC Analysis
DCF valuation, AI insights, and institutional ownership data
Frequently Asked Questions
When is BCYC next earnings date?
BCYC (Bicycle Therapeutics Ltd) has not yet announced its next earnings date. Check back for updates on the upcoming earnings schedule.
What is BCYC earnings per share (EPS)?
BCYC's current earnings per share (EPS) is $-3.62. With a P/E ratio of -1.5, the market values each dollar of earnings at $-1.5.
How often does BCYC report earnings?
Like most publicly traded US companies, BCYC (Bicycle Therapeutics Ltd) reports earnings quarterly, typically within 4-6 weeks after each fiscal quarter ends. The company holds an earnings call to discuss results with analysts.
What time does BCYC report earnings?
BCYC typically reports earnings either before market open (BMO) or after market close (AMC). The exact time is usually announced a few days before the earnings date. Check the investor relations page for specific timing.
How has BCYC performed in recent earnings?
In the most recent quarter (Q4 2024), BCYC reported EPS of $-2.90 on revenue of $0.04B.
What do analysts expect for BCYC earnings?
Analyst expectations for BCYC earnings can vary. The company has shown positive revenue growth of 338.5%. View the full analyst ratings page for detailed expectations.